Barchart.com
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Disc Medicine Inc (IRON)

Disc Medicine Inc (IRON)
40.23 x 3 40.25 x 1
Post-market by (Cboe BZX)
40.27 +1.54 (+3.98%) 04/14/25 [NASDAQ]
40.23 x 3 40.25 x 1
Post-market 40.27 unch (unch) 16:02 ET
News & Headlines for Mon, Apr 14th, 2025
Notes
Alerts
Watch
    Add or delete the symbol from one or more Watchlists.
  • Create New Watchlist
    This name already in use.
Help
Go To:
Disc Medicine Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update GlobeNewswire - Thu Feb 27, 7:00AM CST

IRON : 40.27 (+3.98%)
Disc Medicine to Participate in Upcoming Investor Conferences GlobeNewswire - Wed Feb 26, 7:00AM CST

IRON : 40.27 (+3.98%)
Disc Medicine Announces Pricing of $225.5 Million Upsized Public Offering of Common Stock and Pre-Funded Warrants GlobeNewswire - Wed Jan 22, 8:35PM CST

IRON : 40.27 (+3.98%)
Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants GlobeNewswire - Tue Jan 21, 3:01PM CST

IRON : 40.27 (+3.98%)
Disc Medicine Announces Successful Type C Meeting with FDA for Bitopertin in Erythropoietic Protoporphyria (EPP) and Shares Plans for NDA Submission GlobeNewswire - Tue Jan 21, 6:45AM CST

IRON : 40.27 (+3.98%)
Disc Medicine to Host Conference Call on Type C Meeting for Bitopertin in Erythropoietic Protoporphyria (EPP) GlobeNewswire - Mon Jan 20, 6:00PM CST

IRON : 40.27 (+3.98%)
Disc Medicine Reports Inducement Grant under Nasdaq Listing Rule 5635(C)(4) GlobeNewswire - Fri Jan 17, 3:00PM CST

IRON : 40.27 (+3.98%)
Disc Medicine Highlights Recent Achievements Across Hematology Portfolio and Key Business Objectives and Milestones for 2025 GlobeNewswire - Fri Jan 10, 8:00AM CST

IRON : 40.27 (+3.98%)
Disc Medicine Presents Positive Clinical and Translational Data Across Portfolio at the 66th American Society of Hematology (ASH) Annual Meeting GlobeNewswire - Mon Dec 9, 2024

IRON : 40.27 (+3.98%)
Disc Medicine Reports Positive Phase 1b Results for DISC-0974 in Myelofibrosis Anemia and Initiates Phase 2 Study Quiver Quantitative, Inc. - Mon Dec 9, 2024

Disc Medicine's DISC-0974 shows positive hematologic responses in myelofibrosis anemia, leading to a Phase 2 trial initiation.Quiver AI SummaryDisc Medicine, Inc. announced positive results from a Phase...

IRON : 40.27 (+3.98%)

Barchart Exclusives

Should You Buy Apple Stock on the ‘Liberation Day’ Dip? Barchart - 6 minutes ago
Down almost 25% from all-time highs, Apple stock is unlikely to deliver outsized gains to long-term shareholders despite the ongoing pullback in valuation. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
UTC
Reserve Your Spot